Tylenol /00020001/


Combined with:

Enbrel

Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 24.5%
Liver Transplant 17.0%
Pain 17.0%
Agitation 5.7%
Back Pain 3.8%
Multiple Sclerosis 3.8%
Muscle Spasms 3.8%
Rheumatoid Arthritis 3.8%
Herpes Zoster 1.9%
Hiv Infection 1.9%
Hypersensitivity 1.9%
Juvenile Idiopathic Arthritis 1.9%
Migraine 1.9%
Muscle Relaxant Therapy 1.9%
Myelodysplastic Syndrome 1.9%
Osteoporosis Postmenopausal 1.9%
Premedication 1.9%
Pruritus 1.9%
Psoriatic Arthropathy 1.9%
Renal Tubular Acidosis 23.1%
Acute Hepatic Failure 15.4%
Hepatic Enzyme Increased 7.7%
Multiple Sclerosis 7.7%
Renal Failure 7.7%
Skin Disorder 7.7%
Staphylococcal Infection 7.7%
Suicide Attempt 7.7%
Urticaria 7.7%
Vomiting 7.7%
Concomitant
Product Used For Unknown Indication 47.6%
Premedication 19.2%
Gout 7.6%
Allergy Prophylaxis 4.2%
Pain 3.8%
Hepatitis C 2.7%
Rheumatoid Arthritis 2.6%
Hypertension 1.7%
Prophylaxis 1.3%
Multiple Sclerosis 1.1%
Anxiety 1.0%
Osteoporosis 1.0%
Gouty Tophus 0.9%
Ill-defined Disorder 0.9%
Osteoporosis Postmenopausal 0.9%
Constipation 0.8%
Psoriatic Arthropathy 0.7%
Nausea 0.7%
Pyrexia 0.7%
Diabetes Mellitus 0.7%
Therapeutic Response Decreased 18.3%
Vomiting 9.1%
Infusion Related Reaction 7.9%
Drug Ineffective 7.6%
Sinusitis 6.1%
Weight Decreased 6.1%
Pneumonia 4.0%
Pyrexia 4.0%
Urinary Tract Infection 4.0%
Injection Site Pain 3.7%
Pain In Extremity 3.7%
Headache 3.4%
Pain 3.4%
Urticaria 3.4%
Upper Respiratory Tract Infection 3.0%
Injection Site Swelling 2.7%
Nasopharyngitis 2.4%
Nausea 2.4%
Rash 2.4%
Weight Increased 2.4%

Drug Data